Details

Title
Neutralizing antibodies against SARS-CoV-2 virus after vaccination in patients with neurofibromatosis type 1
Author
Ruan, Qiao-ling 1 ; Wang, Zhi-chao 2   VIAFID ORCID Logo  ; Wei, Cheng-jiang 2 ; Wang, Wei 2 ; Yang, Qing-luan 1 ; Wu, Jing 1 ; Wan, Yan-min 1   VIAFID ORCID Logo  ; Ge, Ling-ling 2 ; Zhang, Wen-hong 3 ; Li, Qing-feng 2   VIAFID ORCID Logo 

 Fudan University, Department of Infectious Diseases, National Medical Center for Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Shanghai, People’s Republic of China (GRID:grid.8547.e) (ISNI:0000 0001 0125 2443) 
 Shanghai Jiao Tong University School of Medicine, Department of Plastic and Reconstructive Surgery, Shanghai Ninth People’s Hospital, Shanghai, People’s Republic of China (GRID:grid.16821.3c) (ISNI:0000 0004 0368 8293) 
 Fudan University, Department of Infectious Diseases, National Medical Center for Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Shanghai, People’s Republic of China (GRID:grid.8547.e) (ISNI:0000 0001 0125 2443); Shanghai Huashen Institute of Microbes and Infections, Shanghai, People’s Republic of China (GRID:grid.8547.e) 
Pages
233
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
ISSN
20959907
e-ISSN
20593635
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2821761677
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.